Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma Companies Stick To Their Roots In India As 40 Percent Yearly Growth Is In Sight

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Dusty roads, poor sanitation, rickety primary health centers, low income levels and sparse availability of qualified doctors - hardly a compelling environment for large pharmaceutical companies to grow their businesses but a few are bracing up to the challenges of the great Indian rural market
Advertisement

Related Content

Global Pharma Bidders May Queue Up For A Slice Of Mankind Pharma And Scorching 25 Percent Growth
Global Pharma Bidders May Queue Up For A Slice Of Mankind Pharma And Scorching 25 Percent Growth
Piramal Deal Done, Abbott's India Plunge May Fetch Big Returns, But Integration Challenges, Growth Momentum Critical
Piramal Deal Done, Abbott's India Plunge May Fetch Big Returns, But Integration Challenges, Growth Momentum Critical
Novartis Designs “Arogya Parivar” To Reach Real India In Its Rural Centers
Novartis Designs “Arogya Parivar” To Reach Real India In Its Rural Centers
Advertisement
UsernamePublicRestriction

Register

SC074327

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel